Clinical-grade whole-genome sequencing and 3′ transcriptome analysis of colorectal cancer patients

Background Clinical-grade whole-genome sequencing (cWGS) has the potential to become the standard of care within the clinic because of its breadth of coverage and lack of bias towards certain regions of the genome. Colorectal cancer presents a difficult treatment paradigm, with over 40% of patients presenting at diagnosis with metastatic disease. We hypothesised that cWGS coupled with 3′ transcriptome analysis would give new insights into colorectal cancer. Methods Patients underwent PCR-free whole-genome sequencing and alignment and variant calling using a standardised pipeline to output SNVs, indels, SVs and CNAs. Additional insights into the mutational signatures and tumour biology were gained by the use of 3′ RNA-seq. Results Fifty-four patients were studied in total. Driver analysis identified the Wnt pathway gene APC as the only consistently mutated driver in colorectal cancer. Alterations in the PI3K/mTOR pathways were seen as previously observed in CRC. Multiple private CNAs, SVs and gene fusions were unique to individual tumours. Approximately 30% of patients had a tumour mutational burden of > 10 mutations/Mb of DNA, suggesting suitability for immunotherapy. Conclusions Clinical whole-genome sequencing offers a potential avenue for the identification of private genomic variation that may confer sensitivity to targeted agents and offer patients new options for targeted therapies.

Abstract licence: CC BY-NC-ND

1. 1.

   Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms · 2015

2. 2.

   Detection of Genomic Structural Variants from Next-Generation Sequencing Data · 2015

3. 12.

   A panel of genes methylated with high frequency in colorectal cancer · 2014

4. 24.
   Corrected

   Mutational Processes Molding the Genomes of 21 Breast Cancers · 2012

5. 27.

   Differential expression analysis for sequence count data · 2010

6. 32.
   Corrected

   Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma · 2016

34 more references, whose wording the paper’s licence keeps private.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.